![]() PepGen PepGen is a clinical-stage biotechnology company developing next-generation of oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases. | |||||
Founding Date | Founding Date 2018 | Founding Date 2014 | Founding Date 2000 | Founding Date 2016 | Founding Date 2008 |
Type | Type Public | Type Public | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations Boston, US HQ | Locations HQ | Locations Treize-Septiers, FR HQ | Locations Cambridge, GB HQ | Locations Mulhouse, FR HQ Mulhouse, FR |
Employees | Employees 8127% increase | Employees N/A | Employees 122 | Employees 3014% decrease | Employees 254% increase |
Financial | |||||
Net income | Net income ($89.7m) (FY, 2025) | Net income (kr10.7m) (FY, 2024) | Net income N/A | Net income N/A | Net income N/A |

Audientes is a biotechnology company that develops treatments for muscle diseases.
View company
Clean Cells is a company that specializes in biosafety testings and cell therapy.
View company
Mogrify is a biotech company advancing cell therapies.
View company
CellProthera is a medical biotech company founded in 2008 in Mulhouse (France).
View company